On May 3, 2018 UCB S A ORDINARY SHARES BELGIUM (OTCMKTS:UCBJF) Sellers Increased Their Shorts By 1.21%

May 3, 2018 - By Daniel Cummings

UCB SA (OTCMKTS:UCBJF) Corporate Logo

It was registered an increase on UCB S A ORDINARY SHARES BELGIUM (OTCMKTS:UCBJF)’s shares shorted with 1.21%. FINRA issued shares shorted of UCBJF’s total 200,700 shares. Previously was reported up change of 1.21% from 198,300 shares. Former UCBJF’s position will need 2007 days to recover. It has 100 average volume. 0.17% is UCB S A ORDINARY SHARES BELGIUM float short.

UCBJF reached $75.2423 during the last trading session after $1.5459 change.Currently UCB SA is after 0.00% change in last May 3, 2017. UCBJF has shares volume. UCBJF underperformed the S&P500 by 11.55%.

UCB SA, a biopharmaceutical company, focuses on the discovery and development of medicines and solutions for people living with severe diseases of the immune system or of the central nervous system.The company has $14.48 billion market cap. The Company’s core products include Cimzia for ankylosing spondylitis, axial spondyloarthritis, Crohn??s disease, psoriatic arthritis, and rheumatoid arthritis; Keppra, Vimpat, and Briviact for epilepsy; and Neupro for Parkinson??s disease and restless legs syndrome.The P/E ratio is 15.31. The firm also offers Zyrtec and Xyzal for allergy; Venlafaxine ER for depressive and anxiety disorders; Nootropil for cognitive disorders; and Xyrem for narcolepsy.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: